H2O2-Responsive Anticancer Prodrug: Synthesis, Precision Deuteration in Search of In Vivo Metabolites, and Activation

Eron Saxon1, Dana Stambekova2, Thilini Nimasha Fernando Ponnamperumage1

  • 1Department of Chemistry and Biochemistry and the Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, 2000 E. Kenwood Boulevard, Milwaukee, Wisconsin 53211, United States.

PubMed

Insights

This study introduces a novel boron-based prodrug activated by hydrogen peroxide (H2O2) for targeted cancer therapy. Precision deuteration confirmed oxidative deboronation as the key in vivo activation mechanism, leading to selective cancer cell killing with minimal toxicity.

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Pharmacology

Background:

  • Boron-based prodrugs show promise for selective cancer treatment by responding to reactive oxygen species (ROS).
  • The in vivo activation mechanisms of ROS-responsive prodrugs are not fully understood, limiting their therapeutic optimization.

Purpose of the Study:

  • To design and synthesize a novel hydrogen peroxide (H2O2)-responsive phenylboronic nitrogen mustard prodrug and its deuterated analogue.
  • To elucidate the in vivo activation pathway of ROS-responsive boron-based anticancer prodrugs using isotope-resolved tracking.
  • To evaluate the therapeutic efficacy and safety of the developed prodrug in preclinical cancer models.

Main Methods:

  • Synthesis of a novel H2O2-responsive phenylboronic nitrogen mustard prodrug (10a) and its precisely deuterated analogue (10b).
  • Co-administration of isotopologues 10a and 10b in triple-negative breast cancer xenograft mouse models.
  • Isotope-resolved metabolic tracking to identify in vivo metabolites and elucidate the activation pathway.
  • Assessment of H2O2-inducible DNA-alkylating activity, cancer cell proliferation inhibition, and tumor growth suppression in vivo.

Main Results:

  • Identification of two key metabolites, providing the first definitive in vivo evidence for oxidative deboronation as the primary activation mechanism.
  • Prodrug 10a demonstrated H2O2-inducible DNA-alkylating activity.
  • Selective inhibition of proliferation in high ROS-expressing MDA-MB-468 cancer cells compared to nonmalignant MCF-10A cells.
  • Significant suppression of tumor growth in vivo with no observable toxicity.

Conclusions:

  • Precision deuteration serves as a powerful mechanistic probe for investigating drug activation pathways in vivo.
  • Oxidative deboronation is confirmed as the principal in vivo activation mechanism for this class of ROS-responsive boron-based prodrugs.
  • The developed boron-based prodrug platform offers a rational approach for designing and optimizing targeted cancer therapeutics with enhanced selectivity and safety.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide02:44

Oxidation of Alkenes: Syn Dihydroxylation with Osmium Tetraoxide

Alkenes are converted to 1,2-diols or glycols through a process called dihydroxylation. It involves the addition of two hydroxyl groups across the double bond with two different stereochemical approaches, namely anti and syn. Dihydroxylation using osmium tetroxide progresses with syn stereochemistry.
12.5K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.5K
Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids02:04

Oxidation of Alkenes: Anti Dihydroxylation with Peroxy Acids

Diols are compounds with two hydroxyl groups. In addition to syn dihydroxylation, diols can also be synthesized through the process of anti dihydroxylation. The process involves treating an alkene with a peroxycarboxylic acid to form an epoxide. Epoxides are highly strained three-membered rings with oxygen and two carbons occupying the corners of an equilateral triangle. This step is followed by ring-opening of the epoxide in the presence of an aqueous acid to give a trans diol.
7.2K
Peroxisomes01:24

Peroxisomes

Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
19.9K